ModeRNA specifications


Unique identifier OMICS_04465
Name ModeRNA
Interface Web user interface
Restrictions to use None
Computer skills Basic
Stability Stable
Maintained Yes


  • person_outline Janusz Bujnicki <>

Publication for ModeRNA

ModeRNA in publications

PMCID: 5890606
PMID: 29500292
DOI: 10.1212/WNL.0000000000005255

[…] data in pediatric patients with hunter syndrome and cognitive impairment who are receiving intrathecal idursulfase-it and iv elaprase? ert. (pi: gerard vockley) 10/11/16 - 10/10/18 0.12 cal. months moderna tx, inc. $195,491 mcad study this agreement pursue studies with therapeutic rnas for genetic disorders of fatty acid oxidation. our lab will perform all animal studies and the necessary […]

PMCID: 5908250
PMID: 29590614
DOI: 10.1016/j.celrep.2018.03.001

[…] with the other authors contributing to editing into the final form., declaration of interests , m.s.d. is a consultant for inbios, aviana, and sanofi and on the scientific advisory board of moderna., oral antibiotics increase susceptibility of mice to severe flavivirus disease, oral antibiotics impair development of optimal antiviral t cell responses, oral antibiotics alter bacterial […]

PMCID: 5877485
PMID: 29628926
DOI: 10.3389/fimmu.2018.00600

[…] the immunogenicity of various mrna vaccines (, ). preclinical and clinical studies suggest that non-amplifying mrna vaccines are effective in mice, non-human primates and humans (, ). recently, moderna therapeutics published the results of a phase 1 clinical trial study of a modified mrna vaccine encoding ha protein of avian h10n8 formulated in lipid nanoparticles (lnps) and demonstrated […]

PMCID: 5829823
PMID: 29487230
DOI: 10.1128/mBio.00008-18

[…] participated in editing the final version of the manuscript., as potential conflicts of interest, m.s.d. is a consultant for inbios and sanofi-pasteur and is on the scientific advisory boards of moderna and ovagene, and j.e.c. has served as a consultant for takeda vaccines, sanofi pasteur, pfizer, and novavax, is on the scientific advisory boards of compuvax, gigagen, meissa vaccines, […]

PMCID: 5874648
PMID: 29346287
DOI: 10.3390/vaccines6010007

[…] wild-type and mutant sequences to be incorporated. in particular, the nucleoside-modified mrna-lnp vaccines elicit rapid and durable immune protection and represent promising vaccine candidates. moderna therapeutics is currently sponsoring a phase 1 clinical trial of their mrna-1235 zikv vaccine to assess its safety, tolerability, and immunogenicity in healthy adults (, nct03014089)., […]

To access a full list of publications, you will need to upgrade to our premium service.

ModeRNA institution(s)
Faculty of Biology, Adam Mickiewicz University, Poznan, Poland

ModeRNA reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ModeRNA